1. Home
  2. HRMY vs ANDE Comparison

HRMY vs ANDE Comparison

Compare HRMY & ANDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.03

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Andersons Inc. (The)

ANDE

Andersons Inc. (The)

HOLD

Current Price

$67.48

Market Cap

2.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
ANDE
Founded
2017
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
HRMY
ANDE
Price
$37.03
$67.48
Analyst Decision
Buy
Strong Buy
Analyst Count
9
2
Target Price
$44.11
$75.00
AVG Volume (30 Days)
854.1K
319.7K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
1.03%
EPS Growth
7.97
12.93
EPS
0.55
0.97
Revenue
$868,453,000.00
$11,008,928,000.00
Revenue This Year
$19.75
$7.28
Revenue Next Year
$12.88
$3.57
P/E Ratio
$67.75
$68.35
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$31.84
52 Week High
$40.87
$82.11

Technical Indicators

Market Signals
Indicator
HRMY
ANDE
Relative Strength Index (RSI) 68.61 39.22
Support Level $35.05 $66.03
Resistance Level $39.12 $74.24
Average True Range (ATR) 1.04 2.00
MACD 0.22 -0.38
Stochastic Oscillator 93.53 25.00

Price Performance

Historical Comparison
HRMY
ANDE

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About ANDE Andersons Inc. (The)

Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

Share on Social Networks: